Cargando…

Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α

Non‐small cell lung cancer (NSCLC) has a poor prognosis, and effective therapeutic strategies are lacking. The diabetes drug canagliflozin inhibits NSCLC cell proliferation and the mammalian target of rapamycin (mTOR) pathway, which mediates cell growth and survival, but it is unclear whether this d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Biziotis, Olga‐Demetra, Tsakiridis, Evangelia Evelyn, Ali, Amr, Ahmadi, Elham, Wu, Jianhan, Wang, Simon, Mekhaeil, Bassem, Singh, Kanwaldeep, Menjolian, Gabe, Farrell, Thomas, Abdulkarim, Bassam, Sur, Ranjan K., Mesci, Aruz, Ellis, Peter, Berg, Tobias, Bramson, Jonathan L, Muti, Paola, Steinberg, Gregory R, Tsakiridis, Theodoros
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620129/ https://www.ncbi.nlm.nih.gov/pubmed/37584455 http://dx.doi.org/10.1002/1878-0261.13508

Ejemplares similares

The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy
por: Ali, Amr, et al.
Publicado: (2023)

Combined metformin-salicylate treatment provides improved anti-tumor activity and enhanced radiotherapy response in prostate cancer; drug synergy at clinically relevant doses
por: Tsakiridis, Evangelia E., et al.
Publicado: (2021)

(18)F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer
por: Mesci, Aruz, et al.
Publicado: (2023)

Contemporary real-world radiotherapy outcomes of unresected locally advanced non-small cell lung cancer
por: Gouran-Savadkoohi, Mohammad, et al.
Publicado: (2023)

The diabetes medication Canagliflozin reduces cancer cell proliferation by inhibiting mitochondrial complex-I supported respiration
por: Villani, Linda A., et al.
Publicado: (2016)

Collagen and Calcium Binding EGF Domains 1 (CCBE1) in cancer – a new role past lymphatics?
por: Mesci, Aruz, et al.
Publicado: (2017)

Expression of the glucose transporters GLUT1, GLUT3, GLUT4 and GLUT12 in human cancer cells
por: Barron, Carly, et al.
Publicado: (2012)

Spurious elevation of Prostate‐specific antigen associated with shingles in a prostate cancer patient undergoing active surveillance
por: Mesci, Aruz, et al.
Publicado: (2018)

Metformin-induced reductions in tumor growth involves modulation of the gut microbiome()
por: Broadfield, Lindsay A., et al.
Publicado: (2022)

AMPK β1 reduces tumor progression and improves survival in p53 null mice
por: Houde, Vanessa P., et al.
Publicado: (2017)

Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice
por: Desjardins, Eric M., et al.
Publicado: (2023)

The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada
por: Beers, Craig A., et al.
Publicado: (2023)

Current Evidence of the Role of the Myokine Irisin in Cancer
por: Tsiani, Evangelia, et al.
Publicado: (2021)

Exposure to the Widely Used Pyrethroid Pesticide Deltamethrin, Does Not Exacerbate High Fat Diet Induced Obesity or Insulin Resistance in C57BL/6J Mice
por: Tsakiridis, Evangelia Evelyn, et al.
Publicado: (2021)

Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1α inhibition
por: Wang, Jian, et al.
Publicado: (2023)

Targeting metabolism and AMP-activated kinase with metformin to sensitize non-small cell lung cancer (NSCLC) to cytotoxic therapy: translational biology and rationale for current clinical trials
por: Troncone, Michael, et al.
Publicado: (2017)

Inhibition of human lung cancer cell proliferation and survival by wine
por: Barron, Carly C, et al.
Publicado: (2014)

Prostate-Specific Membrane Antigen (PSMA) Expression Predicts Need for Early Treatment in Prostate Cancer Patients Managed with Active Surveillance
por: Ahmadi, Elham, et al.
Publicado: (2023)

Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK
por: Storozhuk, Y, et al.
Publicado: (2013)

Inhibition of Human Lung Cancer Cell Proliferation and Survival by Post-Exercise Serum Is Associated with the Inhibition of Akt, mTOR, p70 S6K, and Erk1/2
por: Kurgan, Nigel, et al.
Publicado: (2017)

Assessing the bipotency of in vitro-derived neuromesodermal progenitors
por: Tsakiridis, Anestis, et al.
Publicado: (2015)

Initial Development of an Electronic Testis Rigidity Tester
por: Mirilas, Petros, et al.
Publicado: (2011)

Amniotic band syndrome
por: Ioannis, Tsakiridis, et al.
Publicado: (2020)

Elephantiasis in pregnancy
por: Tsakiridis, Ioannis, et al.
Publicado: (2019)

Shaping axial identity during human pluripotent stem cell differentiation to neural crest cells
por: Cooper, Fay, et al.
Publicado: (2022)

Canagliflozin – Beginning of the journey
por: Pandey, Sunil Kumar, et al.
Publicado: (2014)

Canagliflozin attenuates lipotoxicity in cardiomyocytes and protects diabetic mouse hearts by inhibiting the mTOR/HIF-1α pathway
por: Sun, Pengbo, et al.
Publicado: (2021)

HIF-1α and HIF-2α Differently Regulate the Radiation Sensitivity of NSCLC Cells
por: Moreno Roig, Eloy, et al.
Publicado: (2019)

Effects of canagliflozin on serum potassium in the CANagliflozin cardioVascular Assessment Study (CANVAS) Program
por: Weir, Matthew R, et al.
Publicado: (2020)

Nonmedical Use of Prescription Drugs among Medical Students and the Relationship With Illicit Drug, Tobacco, and Alcohol Use
por: Papazisis, Georgios, et al.
Publicado: (2018)

Crystal structure of canagliflozin hemihydrate
por: Liu, Kai-Hang, et al.
Publicado: (2016)

Chronic modulation of AMP-Kinase, Akt and mTOR pathways by ionizing radiation in human lung cancer xenografts
por: Storozhuk, Yaryna, et al.
Publicado: (2012)

CHUK/IKK-α loss in lung epithelial cells enhances NSCLC growth associated with HIF up-regulation
por: Chavdoula, Evangelia, et al.
Publicado: (2019)

Canagliflozin Ameliorates Oxidative Stress and Autistic-like Features in Valproic-Acid-Induced Autism in Rats: Comparison with Aripiprazole Action
por: Nakhal, Mohammed Moutaz, et al.
Publicado: (2023)

Patient profiling in diabetes and role of canagliflozin
por: Amblee, Ambika
Publicado: (2014)

Prolonged diabetic ketoacidosis associated with canagliflozin
por: Sloan, Gordon, et al.
Publicado: (2018)

Repurposing Canagliflozin to target brain aging
por: Jayarathne, Hashan, et al.
Publicado: (2023)

Targeting of CCBE1 by miR-330-3p in human breast cancer promotes metastasis
por: Mesci, Aruz, et al.
Publicado: (2017)

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)
por: Mahaffey, Kenneth W., et al.
Publicado: (2018)

CANadian CAnagliflozin REgistry: Effectiveness and safety of canagliflozin in the treatment of type 2 diabetes mellitus in Canadian clinical practice
por: Woo, Vincent, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ioo056d16c88l63j6sfcotak5c